Literature DB >> 19211455

Surrogate and mediating endpoints: current status and future directions.

Ross L Prentice.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19211455     DOI： 10.1093/jnci/djn515

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

Review 2.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

3.  Evidence-based mechanistic reasoning.

Authors:  Jeremy Howick; Paul Glasziou; Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

4.  Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia.

Authors:  Stephanie Guidez; Julien Labreuche; Elodie Drumez; Loic Ysebaert; Jana Bakala; Caroline Delette; Bénédicte Hivert; Caroline Protin; Hervé Declercq; Mélanie Verlay; Jean Pierre Marolleau; Alain Duhamel; Pierre Morel
Journal:  Blood Adv       Date:  2018-11-27

5.  CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Authors:  Payam Nahid; Jussi Saukkonen; William R Mac Kenzie; John L Johnson; Patrick P J Phillips; Janet Andersen; Erin Bliven-Sizemore; John T Belisle; W Henry Boom; Annie Luetkemeyer; Thomas B Campbell; Kathleen D Eisenach; Richard Hafner; Jeffrey L Lennox; Mamodikoe Makhene; Susan Swindells; M Elsa Villarino; Marc Weiner; Constance Benson; William Burman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

Review 6.  Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group.

Authors:  Elizabeth A Yetley; Amanda J MacFarlane; Linda S Greene-Finestone; Cutberto Garza; Jamy D Ard; Stephanie A Atkinson; Dennis M Bier; Alicia L Carriquiry; William R Harlan; Dale Hattis; Janet C King; Daniel Krewski; Deborah L O'Connor; Ross L Prentice; Joseph V Rodricks; George A Wells
Journal:  Am J Clin Nutr       Date:  2016-12-07       Impact factor: 7.045

7.  Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis.

Authors:  Sophia Koo; Julie M Bryar; Lindsey R Baden; Francisco M Marty
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

8.  Developing imaging strategies for castration resistant prostate cancer.

Authors:  Josef J Fox; Michael J Morris; Steven M Larson; Heiko Schöder; Howard I Scher
Journal:  Acta Oncol       Date:  2011-06       Impact factor: 4.089

9.  Surrogate disease markers as substitutes for chronic disease outcomes in studies of diet and chronic disease relations.

Authors:  Elizabeth A Yetley; David L DeMets; William R Harlan
Journal:  Am J Clin Nutr       Date:  2017-10-11       Impact factor: 7.045

Review 10.  Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.

Authors:  Michael J Evans
Journal:  Cancer Discov       Date:  2012-10-05       Impact factor: 39.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.